胞性線維症における肺血管形態
Qiwei Xiao1, Goutham Mylavarapu1, James F Chmiel2
1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
まとめ
胞性線維症 (CF) の小血管喪失は,正常な肺機能と早期の治療でも幼児期に始まります. 旧型のCF調節剤とは異なり,トリカフタ療法はこの減少を防ぎました.
科学分野:
- 肺病薬
- 放射線科
- 心肺画像検査
背景:
- 胞性線維症 (CF) の肺血管の変化は完全に理解されていません.
- 老化,疾患の進行,および調節療法がCFの肺血管に影響を与える可能性があります.
研究 の 目的:
- CF患者の肺血管の形態的変化を調査する.
- 年齢,疾患の重症度,および調節器療法による小血管容量の影響を評価する.
主な方法:
- 高解像度CTスキャンと肺機能検査は65人のCF被験者に実施された.
- 小血管の体積と全血管の体積の比率 (BV5/ TBV%) を計算した.
- BV5/ TBV%の変化を異なる治療群で比較して,変調剤効果を分析した.
主要な成果:
- FEV1%の減少とは無関係に,BV5/ TBV%がCF患者における最初の10年間に減少した.
- この減少は,拡散と運動能力の低下と関連していた.
- 健康な対照群やトリカフタで治療された群では,BV5/ TBV%の有意な減少は見られなかった.
結論:
- 肺機能が正常であっても CFの小血管の消耗は早期に始まります
- 第一世代の調節器療法は,この減少を防ぐことができなかった.
- トリカフタ療法は,CFにおける小血管喪失の進行を止めるようでした.
関連する概念動画
Cystic Fibrosis: Pathogenesis
360
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
360
Pulmonary Hypertension: Classification and Pathogenesis
285
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
285
Cystic Fibrosis: Management
223
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
223
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


